Technical Analysis for LPTX - LEAP THERAPEUTICS, INC.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 2.59 | -4.07% | -0.11 |
LPTX closed down 4.07 percent on Wednesday, November 20, 2024, on 69 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 200 DMA | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
200 DMA Support | Bullish | -4.07% | |
Stochastic Buy Signal | Bullish | -4.07% | |
Wide Bands | Range Expansion | -4.07% | |
Oversold Stochastic | Weakness | -4.07% | |
MACD Bearish Centerline Cross | Bearish | -6.83% |
Alert | Time |
---|---|
Down 5% | about 18 hours ago |
Possible NR7 | about 18 hours ago |
60 Minute Opening Range Breakdown | about 20 hours ago |
Down 3% | about 20 hours ago |
200 DMA Support | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Leap Therapeutics, Inc. is a biopharmaceutical company. It develops novel therapeutics for the treatment of cancer. Leap Therapeutics, Inc. is based in Cambridge, United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Treatment Of Cancer Regulus Therapeutics
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Treatment Of Cancer Regulus Therapeutics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.0 |
52 Week Low | 1.68 |
Average Volume | 300,813 |
200-Day Moving Average | 2.66 |
50-Day Moving Average | 2.93 |
20-Day Moving Average | 3.41 |
10-Day Moving Average | 2.99 |
Average True Range | 0.32 |
RSI (14) | 37.11 |
ADX | 23.43 |
+DI | 21.72 |
-DI | 21.88 |
Chandelier Exit (Long, 3 ATRs) | 3.83 |
Chandelier Exit (Short, 3 ATRs) | 3.51 |
Upper Bollinger Bands | 4.46 |
Lower Bollinger Band | 2.35 |
Percent B (%b) | 0.11 |
BandWidth | 61.83 |
MACD Line | -0.08 |
MACD Signal Line | 0.06 |
MACD Histogram | -0.1383 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.82 | ||||
Resistance 3 (R3) | 2.83 | 2.76 | 2.78 | ||
Resistance 2 (R2) | 2.76 | 2.71 | 2.76 | 2.76 | |
Resistance 1 (R1) | 2.68 | 2.67 | 2.65 | 2.67 | 2.75 |
Pivot Point | 2.61 | 2.61 | 2.60 | 2.61 | 2.61 |
Support 1 (S1) | 2.53 | 2.56 | 2.50 | 2.52 | 2.43 |
Support 2 (S2) | 2.46 | 2.52 | 2.46 | 2.42 | |
Support 3 (S3) | 2.38 | 2.46 | 2.40 | ||
Support 4 (S4) | 2.37 |